{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:33:03Z","timestamp":1792611183438,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.cll.2010.01.001","type":"journal-article","created":{"date-parts":[[2010,6,1]],"date-time":"2010-06-01T12:32:01Z","timestamp":1275395521000},"page":"237-260","source":"Crossref","is-referenced-by-count":236,"title":["Yellow Fever: A Reemerging Threat"],"prefix":"10.1016","volume":"30","author":[{"given":"Christina L.","family":"Gardner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate D.","family":"Ryman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2010.01.001_bib1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0065-3527(03)61007-9","article-title":"Epidemiology and ecology of yellow fever virus","volume":"61","author":"Barrett","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.cll.2010.01.001_bib2","series-title":"Yellow fever: an epidemiological and historical study of its place of origin","author":"Carter","year":"1931"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib3","first-page":"216","article-title":"Centennial year of yellow fever eradication in New Orleans and the United States, 1905\u20132005","volume":"157","author":"Tomlinson","year":"2005","journal-title":"La State Med Soc"},{"issue":"8","key":"10.1016\/j.cll.2010.01.001_bib4","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1001\/jama.300.8.960","article-title":"Yellow fever: 100 years of discovery","volume":"300","author":"Staples","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1084\/jem.65.6.801","article-title":"The adaptation of unmodified strains of yellow fever virus to cultivation in vitro","volume":"65","author":"Smith","year":"1937","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib6","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1084\/jem.65.6.767","article-title":"The effect of prolonged cultivation in vitro upon the pathogenicity of yellow fever virus","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.65.6.787","article-title":"The use of yellow fever virus modified by in vitro cultivation for human immunization","volume":"65","author":"Theiler","year":"1937","journal-title":"J Exp Med"},{"issue":"9611","key":"10.1016\/j.cll.2010.01.001_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(08)60238-X","article-title":"Pathogenic flaviviruses","volume":"371","author":"Gould","year":"2008","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0042-6822(90)90470-C","article-title":"Production of yellow fever virus proteins in infected cells: identification of discrete polyprotein species and analysis of cleavage kinetics using region-specific polyclonal antisera","volume":"177","author":"Chambers","year":"1990","journal-title":"Virology"},{"key":"10.1016\/j.cll.2010.01.001_bib10","series-title":"Fields virology","first-page":"1043","article-title":"Flaviviruses","author":"Burke","year":"2001"},{"issue":"4715","key":"10.1016\/j.cll.2010.01.001_bib11","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1126\/science.4023707","article-title":"Nucleotide sequence of yellow fever virus: implications for flavivirus gene expression and evolution","volume":"229","author":"Rice","year":"1985","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0042-6822(86)90012-7","article-title":"The 3\u2032-nucleotides of flavivirus genomic RNA form a conserved secondary structure","volume":"153","author":"Brinton","year":"1986","journal-title":"Virology"},{"issue":"4","key":"10.1016\/j.cll.2010.01.001_bib13","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.chom.2009.04.001","article-title":"Pathogenesis of flavivirus infections: using and abusing the host cell","volume":"5","author":"Fernandez-Garcia","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"4","key":"10.1016\/j.cll.2010.01.001_bib14","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/sj.emboj.7600064","article-title":"Structure of a flavivirus envelope glycoprotein in its low-pH-induced membrane fusion conformation","volume":"23","author":"Bressanelli","year":"2004","journal-title":"EMBO J"},{"issue":"6972","key":"10.1016\/j.cll.2010.01.001_bib15","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1038\/nature02165","article-title":"Structure of the dengue virus envelope protein after membrane fusion","volume":"427","author":"Modis","year":"2004","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/0042-6822(88)90468-0","article-title":"Sequence and secondary structure analysis of the 5\u2032-terminal region of flavivirus genome RNA","volume":"162","author":"Brinton","year":"1988","journal-title":"Virology"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib17","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1128\/JVI.80.6.2976-2986.2006","article-title":"Dengue virus utilizes a novel strategy for translation initiation when cap-dependent translation is inhibited","volume":"80","author":"Edgil","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cll.2010.01.001_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0065-3527(03)59002-9","article-title":"Molecular biology of flaviviruses","volume":"59","author":"Lindenbach","year":"2003","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.cll.2010.01.001_bib19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0065-3527(08)60316-4","article-title":"Flavivirus replication strategy","volume":"33","author":"Westaway","year":"1987","journal-title":"Adv Virus Res"},{"key":"10.1016\/j.cll.2010.01.001_bib20","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1099\/0022-1317-71-3-593","article-title":"Cell surface expression of yellow fever virus non-structural glycoprotein NS1: consequences of interaction with antibody","volume":"71","author":"Schlesinger","year":"1990","journal-title":"J Gen Virol"},{"issue":"Pt 2","key":"10.1016\/j.cll.2010.01.001_bib21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1099\/0022-1317-70-2-335","article-title":"The synthesis and maturation of a non-structural extracellular antigen from tick-borne encephalitis virus and its relationship to the intracellular NS1 protein","volume":"70","author":"Lee","year":"1989","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cll.2010.01.001_bib22","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/0042-6822(89)90161-X","article-title":"Maturation of Japanese encephalitis virus glycoproteins produced by infected mammalian and mosquito cells","volume":"169","author":"Mason","year":"1989","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/0042-6822(88)90408-4","article-title":"Evidence that the mature form of the flavivirus nonstructural protein NS1 is a dimer","volume":"162","author":"Winkler","year":"1988","journal-title":"Virology"},{"issue":"50","key":"10.1016\/j.cll.2010.01.001_bib24","doi-asserted-by":"crossref","first-page":"19111","DOI":"10.1073\/pnas.0605668103","article-title":"West Nile virus nonstructural protein NS1 inhibits complement activation by binding the regulatory protein factor H","volume":"103","author":"Chung","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib25","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1128\/JVI.63.6.2853-2856.1989","article-title":"Mice immunized with recombinant vaccinia virus expressing dengue 4 virus structural proteins with or without nonstructural protein NS1 are protected against fatal dengue virus encephalitis","volume":"63","author":"Bray","year":"1989","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.cll.2010.01.001_bib26","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1128\/JVI.62.8.3027-3031.1988","article-title":"Immunization of mice with dengue structural proteins and nonstructural protein NS1 expressed by baculovirus recombinant induces resistance to dengue virus encephalitis","volume":"62","author":"Zhang","year":"1988","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.cll.2010.01.001_bib27","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1128\/JVI.80.3.1340-1351.2006","article-title":"Antibodies against West Nile Virus nonstructural protein NS1 prevent lethal infection through Fc gamma receptor-dependent and -independent mechanisms","volume":"80","author":"Chung","year":"2006","journal-title":"J Virol"},{"issue":"17","key":"10.1016\/j.cll.2010.01.001_bib28","doi-asserted-by":"crossref","first-page":"9551","DOI":"10.1128\/JVI.00879-07","article-title":"Antibody recognition of cell surface-associated NS1 triggers Fc-gamma receptor-mediated phagocytosis and clearance of West Nile Virus-infected cells","volume":"81","author":"Chung","year":"2007","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1006\/viro.1993.1198","article-title":"Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain","volume":"193","author":"Arias","year":"1993","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib30","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.virol.2004.07.004","article-title":"The RNA helicase, nucleotide 5\u2032-triphosphatase, and RNA 5\u2032-triphosphatase activities of dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core","volume":"328","author":"Benarroch","year":"2004","journal-title":"Virology"},{"issue":"11","key":"10.1016\/j.cll.2010.01.001_bib31","doi-asserted-by":"crossref","first-page":"6042","DOI":"10.1128\/JVI.65.11.6042-6050.1991","article-title":"Processing of the yellow fever virus nonstructural polyprotein: a catalytically active NS3 proteinase domain and NS2B are required for cleavages at dibasic sites","volume":"65","author":"Chambers","year":"1991","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.cll.2010.01.001_bib32","doi-asserted-by":"crossref","first-page":"8898","DOI":"10.1073\/pnas.87.22.8898","article-title":"Evidence that the N-terminal domain of nonstructural protein NS3 from yellow fever virus is a serine protease responsible for site-specific cleavages in the viral polyprotein","volume":"87","author":"Chambers","year":"1990","journal-title":"Proc Natl Acad Sci U\u00a0S A"},{"issue":"5","key":"10.1016\/j.cll.2010.01.001_bib33","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1128\/JVI.65.5.2467-2475.1991","article-title":"Both nonstructural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins","volume":"65","author":"Falgout","year":"1991","journal-title":"J Virol"},{"key":"10.1016\/j.cll.2010.01.001_bib34","doi-asserted-by":"crossref","first-page":"7549","DOI":"10.1128\/JVI.66.12.7549-7554.1992","article-title":"Processing and localization of Dengue virus type 2 polyprotein precursor NS3-NS4A-NS4B-NS5","volume":"66","author":"Zhang","year":"1992","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.cll.2010.01.001_bib35","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1128\/JVI.73.4.3108-3116.1999","article-title":"The serine protease and RNA-stimulated nucleoside triphosphatase and RNA helicase functional domains of dengue virus type 2 NS3 converge within a region of 20 amino acids","volume":"73","author":"Li","year":"1999","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1006\/viro.1994.1103","article-title":"Mutagenesis of the yellow fever virus NS2A\/2B cleavage site: effects on proteolytic processing, viral replication, and evidence for alternative processing of the NS2A protein","volume":"199","author":"Nestorowicz","year":"1994","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib37","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1128\/JVI.67.2.989-996.1993","article-title":"RNA-stimulated NTPase activity associated with yellow fever virus NS3 protein expressed in bacteria","volume":"67","author":"Warrener","year":"1993","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.cll.2010.01.001_bib38","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1093\/emboj\/21.11.2757","article-title":"An RNA cap (nucleoside-2\u2032-O-)-methyltransferase in the flavivirus RNA polymerase NS5: crystal structure and functional characterization","volume":"21","author":"Egloff","year":"2002","journal-title":"EMBO J"},{"issue":"12","key":"10.1016\/j.cll.2010.01.001_bib39","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1261\/rna.1609709","article-title":"The flavivirus NS5 protein is a true RNA guanylyltransferase that catalyzes a two-step reaction to form the RNA cap structure","volume":"15","author":"Issur","year":"2009","journal-title":"RNA"},{"issue":"17","key":"10.1016\/j.cll.2010.01.001_bib40","doi-asserted-by":"crossref","first-page":"8362","DOI":"10.1128\/JVI.00814-06","article-title":"West Nile virus 5\u2032-cap structure is formed by sequential guanine N-7 and ribose 2\u2032-O methylations by nonstructural protein 5","volume":"80","author":"Ray","year":"2006","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib41","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/0042-6822(87)90275-3","article-title":"Characterization of Kunjin virus RNA-dependent RNA polymerase: reinitiation of synthesis in vitro","volume":"157","author":"Chu","year":"1987","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.cll.2010.01.001_bib42","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/JVI.60.3.1113-1124.1986","article-title":"Characterization of West Nile virus RNA-dependent RNA polymerase and cellular terminal adenylyl and uridylyl transferases in cell-free extracts","volume":"60","author":"Grun","year":"1986","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib43","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0166-0934(00)00270-6","article-title":"Expression and purification of enzymatically active recombinant RNA-dependent RNA polymerase (NS5) of the flavivirus Kunjin","volume":"92","author":"Guyatt","year":"2001","journal-title":"J Virol Methods"},{"issue":"5","key":"10.1016\/j.cll.2010.01.001_bib44","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nrmicro1890","article-title":"Modification of intracellular membrane structures for virus replication","volume":"6","author":"Miller","year":"2008","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.cll.2010.01.001_bib45","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1006\/viro.1996.0307","article-title":"Immunolocalization of the dengue virus nonstructural glycoprotein NS1 suggests a role in viral RNA replication","volume":"220","author":"Mackenzie","year":"1996","journal-title":"Virology"},{"key":"10.1016\/j.cll.2010.01.001_bib46","doi-asserted-by":"crossref","first-page":"9555","DOI":"10.1128\/JVI.73.11.9555-9567.1999","article-title":"Markers for trans-Golgi membranes and the intermediate compartment localize to induced membranes with distinct replication functions in flavivirus-infected cells","volume":"73","author":"Mackenzie","year":"1999","journal-title":"J Virol"},{"issue":"4","key":"10.1016\/j.cll.2010.01.001_bib47","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.chom.2009.03.007","article-title":"Composition and three-dimensional architecture of the dengue virus replication and assembly sites","volume":"5","author":"Welsch","year":"2009","journal-title":"Cell Host Microbe"},{"issue":"9","key":"10.1016\/j.cll.2010.01.001_bib48","doi-asserted-by":"crossref","first-page":"6650","DOI":"10.1128\/JVI.71.9.6650-6661.1997","article-title":"Ultrastructure of Kunjin virus-infected cells: colocalization of NS1 and NS3 with double-stranded RNA, and of NS2B with NS3, in virus-induced membrane structures","volume":"71","author":"Westaway","year":"1997","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.cll.2010.01.001_bib49","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1128\/JVI.80.9.4623-4632.2006","article-title":"Regulated cleavages at the West Nile virus NS4A-2K-NS4B junctions play a major role in rearranging cytoplasmic membranes and Golgi trafficking of the NS4A protein","volume":"80","author":"Roosendaal","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.cll.2010.01.001_bib50","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1099\/vir.0.82552-0","article-title":"West Nile virus strain Kunjin NS5 polymerase is a phosphoprotein localized at the cytoplasmic site of viral RNA synthesis","volume":"88","author":"Mackenzie","year":"2007","journal-title":"J Gen Virol"},{"issue":"Pt 11","key":"10.1016\/j.cll.2010.01.001_bib51","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1099\/vir.0.83125-0","article-title":"West Nile virus-induced cytoplasmic membrane structures provide partial protection against the interferon-induced antiviral MxA protein","volume":"88","author":"Hoenen","year":"2007","journal-title":"J Gen Virol"},{"issue":"7","key":"10.1016\/j.cll.2010.01.001_bib52","doi-asserted-by":"crossref","first-page":"4370","DOI":"10.1128\/JVI.77.7.4370-4382.2003","article-title":"Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus","volume":"77","author":"Lorenz","year":"2003","journal-title":"J Virol"},{"issue":"22","key":"10.1016\/j.cll.2010.01.001_bib53","doi-asserted-by":"crossref","first-page":"10787","DOI":"10.1128\/JVI.75.22.10787-10799.2001","article-title":"Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively","volume":"75","author":"Mackenzie","year":"2001","journal-title":"J Virol"},{"key":"10.1016\/j.cll.2010.01.001_bib54","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF01317484","article-title":"An electron and immunoelectron microscopic study of dengue-2 virus infection of cultured mosquito cells: maturation events","volume":"92","author":"Hase","year":"1987","journal-title":"Arch Virol"},{"issue":"Pt 6","key":"10.1016\/j.cll.2010.01.001_bib55","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1099\/0022-1317-72-6-1323","article-title":"Fusion activity of flaviviruses: comparison of mature and immature (prM-containing) tick-borne encephalitis virions","volume":"72","author":"Guirakhoo","year":"1991","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.cll.2010.01.001_bib56","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1126\/science.1153264","article-title":"Structure of the immature dengue virus at low pH primes proteolytic maturation","volume":"319","author":"Yu","year":"2008","journal-title":"Science"},{"issue":"5871","key":"10.1016\/j.cll.2010.01.001_bib57","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1126\/science.1153263","article-title":"The flavivirus precursor membrane-envelope protein complex: structure and maturation","volume":"319","author":"Li","year":"2008","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib58","first-page":"23","volume":"41","author":"Rosen","year":"1981","journal-title":"Med Trop (Mars)"},{"issue":"Suppl 3","key":"10.1016\/j.cll.2010.01.001_bib59","doi-asserted-by":"crossref","first-page":"69S","DOI":"10.4269\/ajtmh.1987.37.69S","article-title":"Overwintering mechanisms of mosquito-borne arboviruses in temperate climates","volume":"37","author":"Rosen","year":"1987","journal-title":"Am J Trop Med Hyg"},{"issue":"9164","key":"10.1016\/j.cll.2010.01.001_bib60","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(99)00155-5","article-title":"Facing up to re-emergence of urban yellow fever","volume":"353","author":"Monath","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib61","first-page":"775","article-title":"A century of progress in combating yellow fever","volume":"64","author":"Bres","year":"1986","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.cll.2010.01.001_bib62","first-page":"341","article-title":"Yellow fever as an endemic\/epidemic disease and priorities for vaccination","volume":"99","author":"Monath","year":"2006","journal-title":"Bull Soc Pathol Exot"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib63","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S1473-3099(01)00016-0","article-title":"Yellow fever: an update","volume":"1","author":"Monath","year":"2001","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cll.2010.01.001_bib64","series-title":"CDC health information for international travel 2010","author":"Brunette","year":"2009"},{"key":"10.1016\/j.cll.2010.01.001_bib65","doi-asserted-by":"crossref","first-page":"e483","DOI":"10.1371\/journal.pntd.0000483","article-title":"Assessment of yellow fever epidemic risk: an original multi-criteria modeling approach","volume":"3","author":"Briand","year":"2009","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib66","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.3201\/eid1006.030738","article-title":"Yellow fever outbreak, Imatong, southern Sudan","volume":"10","author":"Onyango","year":"2004","journal-title":"Emerg Infect Dis"},{"issue":"14","key":"10.1016\/j.cll.2010.01.001_bib67","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.1996.03540140045025","article-title":"Yellow fever: a decade of reemergence","volume":"276","author":"Robertson","year":"1996","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.cll.2010.01.001_bib68","doi-asserted-by":"crossref","first-page":"e75","DOI":"10.1371\/journal.ppat.0030075","article-title":"Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas","volume":"3","author":"Bryant","year":"2007","journal-title":"PLoS Pathog"},{"issue":"40","key":"10.1016\/j.cll.2010.01.001_bib69","first-page":"349","article-title":"Yellow fever vaccine. WHO position paper","volume":"78","author":"World Health Organisation","year":"2003","journal-title":"Wkly Epidemiol Rec"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib70","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4269\/ajtmh.1991.45.1","article-title":"Yellow fever: Victor, Victoria? Conqueror, conquest? Epidemics and research in the last forty years and prospects for the future","volume":"45","author":"Monath","year":"1991","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.cll.2010.01.001_bib71","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0035-9203(89)90518-X","article-title":"Urban yellow fever epidemic in western Nigeria 1987","volume":"83","author":"Nasidi","year":"1989","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.cll.2010.01.001_bib72","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1146\/annurev.ento.52.110405.091454","article-title":"Yellow fever: a disease that has yet to be conquered","volume":"52","author":"Barrett","year":"2007","journal-title":"Annu Rev Entomol"},{"issue":"10","key":"10.1016\/j.cll.2010.01.001_bib73","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1086\/340104","article-title":"Prevention of yellow fever in persons traveling to the tropics","volume":"34","author":"Monath","year":"2002","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib74","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.antiviral.2007.10.009","article-title":"Treatment of yellow fever","volume":"78","author":"Monath","year":"2008","journal-title":"Antiviral Res"},{"key":"10.1016\/j.cll.2010.01.001_bib75","first-page":"663","article-title":"The pathology of the liver in yellow fever","volume":"6","author":"Klotz","year":"1930","journal-title":"Am J Pathol"},{"issue":"1-2","key":"10.1016\/j.cll.2010.01.001_bib76","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0344-0338(11)81176-3","article-title":"Human fatal yellow fever. Immunohistochemical detection of viral antigens in the liver, kidney and heart","volume":"188","author":"De Brito","year":"1992","journal-title":"Pathol Res Pract"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib77","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.virol.2005.09.058","article-title":"Revisiting the liver in human yellow fever: virus-induced apoptosis in hepatocytes associated with TGF-beta, TNF-alpha and NK cells activity","volume":"345","author":"Quaresma","year":"2006","journal-title":"Virology"},{"issue":"10","key":"10.1016\/j.cll.2010.01.001_bib78","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1086\/425016","article-title":"Activation of the cytokine network and unfavorable outcome in patients with yellow fever","volume":"190","author":"ter Meulen","year":"2004","journal-title":"J Infect Dis"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib79","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.virol.2005.07.035","article-title":"Yellow fever virus strains Asibi and 17D-204 infect human umbilical cord endothelial cells and induce novel changes in gene expression","volume":"342","author":"Khaiboullina","year":"2005","journal-title":"Virology"},{"key":"10.1016\/j.cll.2010.01.001_bib80","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S0065-3527(03)60009-6","article-title":"Pathogenesis and pathophysiology of yellow fever","volume":"60","author":"Monath","year":"2003","journal-title":"Adv Virus Res"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib81","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1093\/clinids\/9.1.165","article-title":"Yellow fever: a medically neglected disease. Report on a seminar","volume":"9","author":"Monath","year":"1987","journal-title":"Rev Infect Dis"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib82","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1093\/infdis\/164.6.1119","article-title":"Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome","volume":"164","author":"Huggins","year":"1991","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2010.01.001_bib83","first-page":"647","article-title":"Effect of human gamma interferon on yellow fever virus infection","volume":"38","author":"Arroyo","year":"1988","journal-title":"Am J Trop Med Hyg"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib84","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1006\/biol.1997.0056","article-title":"Yellow fever vaccines","volume":"25","author":"Barrett","year":"1997","journal-title":"Biologicals"},{"issue":"4","key":"10.1016\/j.cll.2010.01.001_bib85","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/14760584.4.4.553","article-title":"Yellow fever vaccine","volume":"4","author":"Monath","year":"2005","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.cll.2010.01.001_bib86","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4161\/hv.1.5.2221","article-title":"Yellow fever 17D vaccine safety and immunogenicity in the elderly","volume":"1","author":"Monath","year":"2005","journal-title":"Hum Vaccin"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib87","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/(SICI)1096-9071(199810)56:2<159::AID-JMV10>3.0.CO;2-B","article-title":"Development of viremia and humoral and cellular parameters of immune activation after vaccination with yellow fever virus strain 17D: a model of human flavivirus infection","volume":"56","author":"Reinhardt","year":"1998","journal-title":"J Med Virol"},{"issue":"12","key":"10.1016\/j.cll.2010.01.001_bib88","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1046\/j.1365-3156.1999.00496.x","article-title":"Assessment of IgG antibodies against yellow fever virus after vaccination with 17D by different assays: neutralization test, haemagglutination inhibition test, immunofluorescence assay and ELISA","volume":"4","author":"Niedrig","year":"1999","journal-title":"Trop Med Int Health"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib89","first-page":"895","article-title":"Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine","volume":"59","author":"Poland","year":"1981","journal-title":"Bull World Health Organ"},{"issue":"Pt 1","key":"10.1016\/j.cll.2010.01.001_bib90","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1099\/vir.0.82272-0","article-title":"Restricted replication and lysosomal trafficking of yellow fever 17D vaccine virus in human dendritic cells","volume":"88","author":"Palmer","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.cll.2010.01.001_bib91","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J Exp Med"},{"issue":"9","key":"10.1016\/j.cll.2010.01.001_bib92","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1084\/jem.20051352","article-title":"Live attenuated yellow fever 17D infects human DCs and allows for presentation of endogenous and recombinant T cell epitopes","volume":"202","author":"Barba-Spaeth","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.cll.2010.01.001_bib93","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1046\/j.1365-2249.2001.01621.x","article-title":"Influence of the IL-1Ra gene polymorphism on in vivo synthesis of IL-1Ra and IL-1beta after live yellow fever vaccination","volume":"125","author":"Hacker","year":"2001","journal-title":"Clin Exp Immunol"},{"issue":"3","key":"10.1016\/j.cll.2010.01.001_bib94","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1086\/517806","article-title":"In vivo synthesis of tumor necrosis factor-alpha in healthy humans after live yellow fever vaccination","volume":"177","author":"Hacker","year":"1998","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.cll.2010.01.001_bib95","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1128\/CDLI.2.3.302-306.1995","article-title":"Lymphocytic 2\u2032,5\u2032-oligoadenylate synthetase activity increases prior to the appearance of neutralizing antibodies and immunoglobulin M and immunoglobulin G antibodies after primary and secondary immunization with yellow fever vaccine","volume":"2","author":"Bonnevie-Nielsen","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"issue":"4","key":"10.1016\/j.cll.2010.01.001_bib96","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/infdis\/169.4.807","article-title":"MxA gene expression after live virus vaccination: a sensitive marker for endogenous type I interferon","volume":"169","author":"Roers","year":"1994","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1006\/viro.2001.1255","article-title":"Human cytotoxic T lymphocyte responses to live attenuated 17D yellow fever vaccine: identification of HLA-B35-restricted CTL epitopes on nonstructural proteins NS1, NS2b, NS3, and the structural protein E","volume":"293","author":"Co","year":"2002","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib98","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/viro.2002.1432","article-title":"Yellow fever virus 17D envelope and NS3 proteins are major targets of the antiviral T cell response in mice","volume":"296","author":"van der Most","year":"2002","journal-title":"Virology"},{"issue":"7","key":"10.1016\/j.cll.2010.01.001_bib99","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1073\/pnas.84.7.2019","article-title":"Comparison of the virulent Asibi strain of yellow fever virus with the 17D vaccine strain derived from it","volume":"84","author":"Hahn","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Pt 11","key":"10.1016\/j.cll.2010.01.001_bib100","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1099\/0022-1317-76-11-2749","article-title":"Comparison of the genomes of the wild-type French viscerotropic strain of yellow fever virus with its vaccine derivative French neurotropic vaccine","volume":"76","author":"Wang","year":"1995","journal-title":"J Gen Virol"},{"issue":"Pt 8","key":"10.1016\/j.cll.2010.01.001_bib101","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1099\/0022-1317-79-8-1895","article-title":"Mutation in NS5 protein attenuates mouse neurovirulence of yellow fever 17D vaccine virus","volume":"79","author":"Xie","year":"1998","journal-title":"J Gen Virol"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib102","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/0168-1702(94)00076-O","article-title":"Complete nucleotide sequence of yellow fever virus vaccine strains 17DD and 17D-213","volume":"35","author":"dos Santos","year":"1995","journal-title":"Virus Res"},{"issue":"9-10","key":"10.1016\/j.cll.2010.01.001_bib103","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/S0264-410X(97)00278-8","article-title":"Genetic variability among yellow fever virus 17D substrains","volume":"16","author":"Galler","year":"1998","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib104","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/viro.1998.9057","article-title":"Mutation in a 17D-204 vaccine substrain-specific envelope protein epitope alters the pathogenesis of yellow fever virus in mice","volume":"244","author":"Ryman","year":"1998","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib105","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/viro.1997.8496","article-title":"Antigenic variants of yellow fever virus with an altered neurovirulence phenotype in mice","volume":"230","author":"Ryman","year":"1997","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib106","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1006\/viro.1999.9873","article-title":"Molecular and biological changes associated with HeLa cell attenuation of wild-type yellow fever virus","volume":"261","author":"Dunster","year":"1999","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.cll.2010.01.001_bib107","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1128\/JVI.77.2.1462-1468.2003","article-title":"Molecular characterization of a hamster viscerotropic strain of yellow fever virus","volume":"77","author":"McArthur","year":"2003","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib108","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1001\/jama.1966.03110190153047","article-title":"Fatal viral encephalitis following 17D yellow fever vaccine inoculation. Report of a case in a 3-year-old child","volume":"198","year":"1966","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib109","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0264-410X(93)90329-V","article-title":"Possible association of encephalitis and 17D yellow fever vaccination in a 29-year-old traveller","volume":"11","author":"Merlo","year":"1993","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.cll.2010.01.001_bib110","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0163-4453(90)90807-K","article-title":"Encephalitis in a 13-year-old boy following 17D yellow fever vaccine","volume":"21","author":"Schoub","year":"1990","journal-title":"J Infect"},{"issue":"44","key":"10.1016\/j.cll.2010.01.001_bib111","first-page":"989","article-title":"Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001-2002","volume":"51","author":"Centers for Disease Control and Prevention (CDC)","year":"2002","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"20","key":"10.1016\/j.cll.2010.01.001_bib112","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1001\/jama.288.20.2533-JWR1127-2-1","article-title":"Adverse events associated with 17D-derived yellow fever vaccination\u2014United States, 2001-2002","volume":"288","author":"From the Centers for Disease Control and Prevention","year":"2002","journal-title":"JAMA"},{"issue":"50","key":"10.1016\/j.cll.2010.01.001_bib113","doi-asserted-by":"crossref","first-page":"8480","DOI":"10.1016\/j.vaccine.2007.08.061","article-title":"Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease","volume":"25","author":"Belsher","year":"2007","journal-title":"Vaccine"},{"issue":"9276","key":"10.1016\/j.cll.2010.01.001_bib114","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(01)05341-7","article-title":"Hepatitis and death following vaccination with 17D-204 yellow fever vaccine","volume":"358","author":"Chan","year":"2001","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.cll.2010.01.001_bib115","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/01.SMJ.0000157537.11806.DC","article-title":"Rare case of fatal yellow fever vaccine-associated viscerotropic disease","volume":"98","author":"Gerasimon","year":"2005","journal-title":"South Med J"},{"issue":"9276","key":"10.1016\/j.cll.2010.01.001_bib116","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0140-6736(01)05327-2","article-title":"Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases","volume":"358","author":"Martin","year":"2001","journal-title":"Lancet"},{"issue":"9276","key":"10.1016\/j.cll.2010.01.001_bib117","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0140-6736(01)05326-0","article-title":"Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases","volume":"358","author":"Vasconcelos","year":"2001","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.cll.2010.01.001_bib118","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1017\/S0950268804002602","article-title":"Risk of fatal adverse events associated with 17DD yellow fever vaccine","volume":"132","author":"Struchiner","year":"2004","journal-title":"Epidemiol Infect"},{"issue":"10","key":"10.1016\/j.cll.2010.01.001_bib119","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.trstmh.2007.06.013","article-title":"Acute viscerotropic disease following vaccination against yellow fever","volume":"101","author":"Hayes","year":"2007","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"4","key":"10.1016\/j.cll.2010.01.001_bib120","first-page":"37","article-title":"Global Advisory Committee on Vaccine Safety, 12-13 December 2007","volume":"83","year":"2008","journal-title":"Wkly Epidemiol Rec"},{"issue":"Annex 2","key":"10.1016\/j.cll.2010.01.001_bib121","first-page":"30","article-title":"Requirements for yellow fever vaccine","volume":"872","author":"WHO","year":"1998","journal-title":"World Health Organ Tech Rep Ser"},{"issue":"5","key":"10.1016\/j.cll.2010.01.001_bib122","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/01.qco.0000178823.28585.ad","article-title":"New developments in flavivirus vaccines with special attention to yellow fever","volume":"18","author":"Pugachev","year":"2005","journal-title":"Curr Opin Infect Dis"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271210000028?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271210000028?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,6,5]],"date-time":"2020-06-05T07:00:08Z","timestamp":1591340408000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271210000028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":122,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0272271210000028"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2010.01.001","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}